These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27256317)

  • 1. Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?
    Dima A; Opris D; Jurcut C; Baicus C
    Lupus; 2016 Oct; 25(11):1173-9. PubMed ID: 27256317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.
    Firooz N; Albert DA; Wallace DJ; Ishimori M; Berel D; Weisman MH
    Lupus; 2011 May; 20(6):588-97. PubMed ID: 21436216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does erythrocyte sedimentation rate reflect and discriminate flare from infection in systemic lupus erythematosus? Correlation with clinical and laboratory parameters of disease activity.
    Schäfer VS; Weiß K; Krause A; Schmidt WA
    Clin Rheumatol; 2018 Jul; 37(7):1835-1844. PubMed ID: 29656375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever.
    Littlejohn E; Marder W; Lewis E; Francis S; Jackish J; McCune WJ; Somers EC
    Lupus; 2018 Jun; 27(7):1123-1129. PubMed ID: 29546774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
    Keenan RT; Swearingen CJ; Yazici Y
    Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of C-reactive protein in systemic lupus erythematosus].
    Cengić M; Heljić B; Rasić S; Dilić M
    Med Arh; 2002; 56(3):147-9. PubMed ID: 12378859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
    Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
    J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus.
    Toldi G; Szalay B; Bekő G; Bocskai M; Deák M; Kovács L; Vásárhelyi B; Balog A
    Biomarkers; 2012 Dec; 17(8):758-63. PubMed ID: 23033975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between mean platelet volume levels and inflammation in SLE patients presented with arthritis.
    Safak S; Uslu AU; Serdal K; Turker T; Soner S; Lutfi A
    Afr Health Sci; 2014 Dec; 14(4):919-24. PubMed ID: 25834502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum procalcitonin and C-reactive protein levels as diagnostic markers for distinguishing bacterial infections from lupus flares in systemic lupus erythematosus: A systematic review and meta‑analysis.
    Chen Y; Shen J; Yang H; Xu S; Ma Y; Pan F
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108304. PubMed ID: 34731783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
    Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
    Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
    Lee YH; Song GG
    PLoS One; 2024; 19(5):e0303665. PubMed ID: 38753735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell distribution width is a potential index to assess the disease activity of systemic lupus erythematosus.
    Hu ZD; Chen Y; Zhang L; Sun Y; Huang YL; Wang QQ; Xu YL; Chen SX; Qin Q; Deng AM
    Clin Chim Acta; 2013 Oct; 425():202-5. PubMed ID: 23954839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of common inflammatory markers in treatment-naïve patients with systemic rheumatic diseases.
    Kim MJ; Lee EB; Song YW; Park JK
    Clin Rheumatol; 2020 Oct; 39(10):2899-2906. PubMed ID: 32314175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A; Nikolaisen C; Nossent HC
    Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6.
    Suh CH; Chun HY; Ye YM; Park HS
    Clin Immunol; 2006 Jun; 119(3):291-6. PubMed ID: 16406714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.
    Kim HA; Jeon JY; An JM; Koh BR; Suh CH
    J Rheumatol; 2012 Apr; 39(4):728-34. PubMed ID: 22337236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
    Suszek D; Górak A; Majdan M
    Rheumatol Int; 2020 Oct; 40(10):1625-1629. PubMed ID: 32772131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.